iShares Biotechnology ETF (IBB)
NASDAQ: IBB · Real-Time Price · USD
140.85
-0.88 (-0.62%)
Dec 3, 2024, 12:34 PM EST - Market open
IBB Holdings List
As of Nov 25, 2024
No. | Symbol | Name | % Weight |
---|---|---|---|
1 | GILD | Gilead Sciences, Inc. | 9.66% |
2 | VRTX | Vertex Pharmaceuticals Incorporated | 7.85% |
3 | AMGN | Amgen Inc. | 7.43% |
4 | REGN | Regeneron Pharmaceuticals, Inc. | 5.34% |
5 | IQV | IQVIA Holdings Inc. | 3.70% |
6 | ALNY | Alnylam Pharmaceuticals, Inc. | 3.20% |
7 | ARGX | argenx SE | 3.08% |
8 | MTD | Mettler-Toledo International Inc. | 2.58% |
9 | BNTX | BioNTech SE | 2.45% |
10 | BIIB | Biogen Inc. | 2.30% |
11 | ILMN | Illumina, Inc. | 2.28% |
12 | WAT | Waters Corporation | 2.24% |
13 | NTRA | Natera, Inc. | 1.91% |
14 | UTHR | United Therapeutics Corporation | 1.61% |
15 | BGNE | BeiGene, Ltd. | 1.57% |
16 | MRNA | Moderna, Inc. | 1.50% |
17 | INCY | Incyte Corporation | 1.40% |
18 | NBIX | Neurocrine Biosciences, Inc. | 1.26% |
19 | INSM | Insmed Incorporated | 1.24% |
20 | BMRN | BioMarin Pharmaceutical Inc. | 1.23% |
21 | GMAB | Genmab A/S | 1.18% |
22 | TECH | Bio-Techne Corporation | 1.17% |
23 | CRL | Charles River Laboratories International, Inc. | 1.03% |
24 | SRPT | Sarepta Therapeutics, Inc. | 1.03% |
25 | EXEL | Exelixis, Inc. | 1.01% |
26 | PCVX | Vaxcyte, Inc. | 0.98% |
27 | MEDP | Medpace Holdings, Inc. | 0.86% |
28 | ITCI | Intra-Cellular Therapies, Inc. | 0.84% |
29 | RVMD | Revolution Medicines, Inc. | 0.80% |
30 | RGEN | Repligen Corporation | 0.76% |
31 | LEGN | Legend Biotech Corporation | 0.66% |
32 | ASND | Ascendis Pharma A/S | 0.64% |
33 | MDGL | Madrigal Pharmaceuticals, Inc. | 0.62% |
34 | BRKR | Bruker Corporation | 0.61% |
35 | HALO | Halozyme Therapeutics, Inc. | 0.60% |
36 | BPMC | Blueprint Medicines Corporation | 0.58% |
37 | CYTK | Cytokinetics, Incorporated | 0.57% |
38 | ROIV | Roivant Sciences Ltd. | 0.55% |
39 | RNA | Avidity Biosciences, Inc. | 0.49% |
40 | ADMA | ADMA Biologics, Inc. | 0.48% |
41 | IONS | Ionis Pharmaceuticals, Inc. | 0.48% |
42 | CRNX | Crinetics Pharmaceuticals, Inc. | 0.48% |
43 | ALKS | Alkermes plc | 0.48% |
44 | KRYS | Krystal Biotech, Inc. | 0.47% |
45 | CRSP | CRISPR Therapeutics AG | 0.41% |
46 | RARE | Ultragenyx Pharmaceutical Inc. | 0.41% |
47 | BBIO | BridgeBio Pharma, Inc. | 0.38% |
48 | AXSM | Axsome Therapeutics, Inc. | 0.38% |
49 | BHVN | Biohaven Ltd. | 0.37% |
50 | ACLX | Arcellx, Inc. | 0.36% |
As of Nov 25, 2024